Greens Hx product offers high density nutrition with plant extracts from 39 super foods including sea greens, soy lecithin, vegetables, herbs, spices, royal jelly, apple pectin, plant enzymes
The transaction, if successfully completed, is expected to create a global specialty pharmaceutical company with around $11bn in combined annual revenue, and the third-largest US specialty pharmaceutical company
Following the transaction, Xellia will revert to Danish ownership with headquarters in Denmark. Xellia develops and manufactures anti-infective therapies for multi-drug resistant infections and supplies Vancomycin and Colistimethate
The recall follows the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer. Methotrexate is an antimetabolite used in the treatment
Global Pharmaceuticals, the generics division of Impax, commenced product shipment, as part of a distribution, license, development and supply agreement with AstraZeneca UK. Zomig is indicated to treat
The trial will test the safety and efficacy of intra-articular injections of autologous human adipose-derived mesenchymal progenitor cells (haMPC) to reduce inflammation and regenerate damaged joint tissues. Cellular
IL-13 is an immune regulatory cytokine and IL-13Ra2 is highly and specifically expressed in glioblastoma, ovarian and other solid tumors, but not in normal tissue. ICT-107 is the
The partnership will leverage DBV’s skin patch, Viaskin, and Stallergenes’ expertise in respiratory allergies in developing immunotherapy treatments for respiratory allergies. DBV Technologies chairman and CEO Dr. Pierre-Henri
The two-stage trial is performed as a double masking test at each stage. It will include around 120 study subjects in the first and second stage studies. R-Tech
The novel anti-IL-6 monoclonal antibody RYI-008 is believed to have a potential to define new paradigm in the treatment of autoimmune diseases and cancer. RuiYi president and CEO
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.